Cargando…
Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia
BACKGROUND: Increasing the availability of antigen rapid diagnostic tests (Ag-RDTs) in low- and middle-income countries (LMICs) is key to alleviating global SARS-CoV-2 testing inequity (median testing rate in December 2021–March 2022 when the Omicron variant was spreading in multiple countries: high...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619661/ https://www.ncbi.nlm.nih.gov/pubmed/36208211 http://dx.doi.org/10.1093/cid/ciac814 |
_version_ | 1784821277457907712 |
---|---|
author | Han, Alvin X Girdwood, Sarah J Khan, Shaukat Sacks, Jilian A Toporowski, Amy Huq, Naushin Hannay, Emma Russell, Colin A Nichols, Brooke E |
author_facet | Han, Alvin X Girdwood, Sarah J Khan, Shaukat Sacks, Jilian A Toporowski, Amy Huq, Naushin Hannay, Emma Russell, Colin A Nichols, Brooke E |
author_sort | Han, Alvin X |
collection | PubMed |
description | BACKGROUND: Increasing the availability of antigen rapid diagnostic tests (Ag-RDTs) in low- and middle-income countries (LMICs) is key to alleviating global SARS-CoV-2 testing inequity (median testing rate in December 2021–March 2022 when the Omicron variant was spreading in multiple countries: high-income countries = 600 tests/100 000 people/day; LMICs = 14 tests/100 000 people/day). However, target testing levels and effectiveness of asymptomatic community screening to impact SARS-CoV-2 transmission in LMICs are unclear. METHODS: We used Propelling Action for Testing and Treating (PATAT), an LMIC-focused agent-based model to simulate coronavirus disease 2019 (COVID-19) epidemics, varying the amount of Ag-RDTs available for symptomatic testing at healthcare facilities and asymptomatic community testing in different social settings. We assumed that testing was a function of access to healthcare facilities and availability of Ag-RDTs. We explicitly modelled symptomatic testing demand from individuals without SARS-CoV-2 and measured impact based on the number of infections averted due to test-and-isolate. RESULTS: Testing symptomatic individuals yields greater benefits than any asymptomatic community testing strategy until most symptomatic individuals who sought testing have been tested. Meeting symptomatic testing demand likely requires at least 200–400 tests/100 000 people/day, on average, as symptomatic testing demand is highly influenced by individuals without SARS-CoV-2. After symptomatic testing demand is satisfied, excess tests to proactively screen for asymptomatic infections among household members yield the largest additional infections averted. CONCLUSIONS: Testing strategies aimed at reducing transmission should prioritize symptomatic testing and incentivizing test-positive individuals to adhere to isolation to maximize effectiveness. |
format | Online Article Text |
id | pubmed-9619661 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-96196612022-11-04 Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia Han, Alvin X Girdwood, Sarah J Khan, Shaukat Sacks, Jilian A Toporowski, Amy Huq, Naushin Hannay, Emma Russell, Colin A Nichols, Brooke E Clin Infect Dis Major Article BACKGROUND: Increasing the availability of antigen rapid diagnostic tests (Ag-RDTs) in low- and middle-income countries (LMICs) is key to alleviating global SARS-CoV-2 testing inequity (median testing rate in December 2021–March 2022 when the Omicron variant was spreading in multiple countries: high-income countries = 600 tests/100 000 people/day; LMICs = 14 tests/100 000 people/day). However, target testing levels and effectiveness of asymptomatic community screening to impact SARS-CoV-2 transmission in LMICs are unclear. METHODS: We used Propelling Action for Testing and Treating (PATAT), an LMIC-focused agent-based model to simulate coronavirus disease 2019 (COVID-19) epidemics, varying the amount of Ag-RDTs available for symptomatic testing at healthcare facilities and asymptomatic community testing in different social settings. We assumed that testing was a function of access to healthcare facilities and availability of Ag-RDTs. We explicitly modelled symptomatic testing demand from individuals without SARS-CoV-2 and measured impact based on the number of infections averted due to test-and-isolate. RESULTS: Testing symptomatic individuals yields greater benefits than any asymptomatic community testing strategy until most symptomatic individuals who sought testing have been tested. Meeting symptomatic testing demand likely requires at least 200–400 tests/100 000 people/day, on average, as symptomatic testing demand is highly influenced by individuals without SARS-CoV-2. After symptomatic testing demand is satisfied, excess tests to proactively screen for asymptomatic infections among household members yield the largest additional infections averted. CONCLUSIONS: Testing strategies aimed at reducing transmission should prioritize symptomatic testing and incentivizing test-positive individuals to adhere to isolation to maximize effectiveness. Oxford University Press 2022-10-08 /pmc/articles/PMC9619661/ /pubmed/36208211 http://dx.doi.org/10.1093/cid/ciac814 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Major Article Han, Alvin X Girdwood, Sarah J Khan, Shaukat Sacks, Jilian A Toporowski, Amy Huq, Naushin Hannay, Emma Russell, Colin A Nichols, Brooke E Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia |
title | Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia |
title_full | Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia |
title_fullStr | Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia |
title_full_unstemmed | Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia |
title_short | Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia |
title_sort | strategies for using antigen rapid diagnostic tests to reduce transmission of severe acute respiratory syndrome coronavirus 2 in low- and middle-income countries: a mathematical modelling study applied to zambia |
topic | Major Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619661/ https://www.ncbi.nlm.nih.gov/pubmed/36208211 http://dx.doi.org/10.1093/cid/ciac814 |
work_keys_str_mv | AT hanalvinx strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia AT girdwoodsarahj strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia AT khanshaukat strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia AT sacksjiliana strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia AT toporowskiamy strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia AT huqnaushin strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia AT hannayemma strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia AT russellcolina strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia AT nicholsbrookee strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia |